clorazepate dipotassium has been researched along with venlafaxine hydrochloride in 1 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (venlafaxine hydrochloride) | Trials (venlafaxine hydrochloride) | Recent Studies (post-2010) (venlafaxine hydrochloride) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 2,846 | 686 | 1,136 |
| Protein | Taxonomy | clorazepate dipotassium (IC50) | venlafaxine hydrochloride (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.9466 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.18 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.55 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papadimitriou, GN; Psarros, C; Sakkas, P; Soldatos, CR; Theleritis, CG | 1 |
1 other study(ies) available for clorazepate dipotassium and venlafaxine hydrochloride
| Article | Year |
|---|---|
Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Clorazepate Dipotassium; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Psychiatric Status Rating Scales; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2006 |